UK Markets closed
  • FTSE 100

    7,765.15
    +4.04 (+0.05%)
     
  • FTSE 250

    20,035.39
    +119.88 (+0.60%)
     
  • AIM

    869.24
    +3.83 (+0.44%)
     
  • GBP/EUR

    1.1404
    +0.0015 (+0.13%)
     
  • GBP/USD

    1.2395
    -0.0012 (-0.0967%)
     
  • BTC-GBP

    19,070.62
    +395.29 (+2.12%)
     
  • CMC Crypto 200

    526.66
    +9.65 (+1.87%)
     
  • S&P 500

    4,070.56
    +10.13 (+0.25%)
     
  • DOW

    33,978.08
    +28.67 (+0.08%)
     
  • CRUDE OIL

    79.38
    -1.63 (-2.01%)
     
  • GOLD FUTURES

    1,943.90
    -2.80 (-0.14%)
     
  • NIKKEI 225

    27,382.56
    +19.81 (+0.07%)
     
  • HANG SENG

    22,688.90
    +122.12 (+0.54%)
     
  • DAX

    15,150.03
    +17.18 (+0.11%)
     
  • CAC 40

    7,097.21
    +1.22 (+0.02%)
     

The Worldwide Cervical Dysplasia Industry is Expected to Reach $977.7 Million by 2027: Rising Initiatives by the Government to Enhance the Screening of Cervical Dysplasia Drives Growth

Company Logo
Company Logo

Global Cervical Dysplasia Market

Global Cervical Dysplasia Market
Global Cervical Dysplasia Market

Dublin, Dec. 29, 2022 (GLOBE NEWSWIRE) -- The "Global Cervical Dysplasia Market (2022-2027) by Diagnostics Type, Treatment Type, End-users, and Geography, with Competitive Analysis, Impact of COVID-19, and Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

The Global Cervical Dysplasia Market is estimated to be worth USD 704.34 million in 2022, and is expected to reach USD 977.76 million by 2027, growing at a CAGR of 6.78%.

Report Attribute

Details

No. of Pages

175

Forecast Period

2022 - 2027

Estimated Market Value (USD) in 2022

$704.34 Million

Forecasted Market Value (USD) by 2027

$977.76 Million

Compound Annual Growth Rate

6.7%

Regions Covered

Global

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors.

There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals. As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

The Competitive Quadrant

The report includes the Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Cervical Dysplasia Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

  • The Global Cervical Dysplasia Market is analyzed using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

  • Based on the SWOT analysis conducted on the industry and industry players, suitable strategies have been devised for market growth.

Why Buy This Report?

  • The report offers a comprehensive evaluation of the Global Cervical Dysplasia Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.

  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel within the industry.

  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of COVID-19 on the market is also featured in the report.

  • The report also includes the regulatory scenario within the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules & regulations imposed on this sector across various geographies.

  • The report also contains competitive analysis using 'Positioning Quadrants'; a proprietary competitive positioning tool.

Market Dynamics

Drivers

  • Increasing Incidences of Cervical Cancer

  • Rising Initiatives by the Government to Enhance the Screening of Cervical Dysplasia

  • Emergence of Cervical Screening Programs

Restraints

  • High Cost of Diagnostic Devices

Opportunities

  • Increasing Awareness Campaigns for the Early Diagnosis

  • Technological Advancements in Screening Devices and Other Supporting Equipment

Challenges

  • Alteration in Regulatory Guidelines for Cervical Cancer Screening and Use of HPV Vaccines

Market Segmentation

The Global Cervical Dysplasia Market is segmented based on Diagnostics Type, Treatment Type, End-users, and Geography.

  • By Diagnostics Type, the market is classified into Biopsy, Colposcopy, HPV Test, and Pap Smear Test.

  • By Treatment Type, the market is classified into Chemotherapy, Radiation Therapy, Surgery, and Therapeutic HPV Vaccines.

  • By End-users, the market is classified into Ambulatory Surgery Centers, Diagnostic Centers, Hospitals, Research & Academic Institutes, and Specialty Clinics.

  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa, and Asia-Pacific.

Companies Mentioned

  • Abbott Laboratories

  • Asieris Pharmaceuticals

  • ASKA Pharmaceutical Co. Ltd.

  • Becton, Dickinson, and Company

  • BetterLife Pharma, Inc.

  • Bristol-Myers Squibb Company

  • Cardinal Health, Inc.

  • CooperSurgical, Inc.

  • DYSIS Medical Ltd.

  • F. Hoffmann La-Roche Ltd.

  • GlaxoSmithKline PLC

  • Guided Therapeutics, Inc.

  • Helix BioPharma Corp.

  • Hologic, Inc.

  • Karl Kaps GmbH & Co. KG

  • KinoPharma, Inc.

  • Micromedic Technologies Ltd.

  • OncoHealth Corp.

  • PDS Biotechnology Company

  • Polaris Pharmaceuticals, Inc.

  • Qiagen N.V.

  • Quest Diagnostics, Inc.

  • ViciniVax B.V.

For more information about this report visit https://www.researchandmarkets.com/r/xjpnpn

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900